Literature DB >> 10931152

Absence of CD40-CD40 ligand interactions in X-linked hyper-IgM syndrome does not affect differentiation of T helper cell subsets.

H Uronen1, R E Callard.   

Abstract

The aim of this study was to investigate the effect of absent CD40-CD40 ligand interactions in patients with X-linked hyper-IgM syndrome (XHIGM) on the generation of Th1 and Th2 immunity. Whole blood from patients and sex- and age-matched controls was stimulated with phorbol myristate acetate (PMA) and calcium ionophore A23187 in the presence of Brefeldin A. After 5 h, cellular production of interferon-gamma, IL-4, tumour necrosis factor-alpha and IL-2 was measured by intracellular cytokine staining and flow cytometry. This method has been shown previously to preferentially activate memory T cells and in preliminary experiments cells making these cytokines were found to be predominantly CD45RO+. No differences in the proportion of T cells (CD3+) or T cell subsets (CD4+/CD8+) secreting these cytokines between XHIGM patients and age- and sex-matched controls were observed. In addition, production of IL-12 and IL-6 by monocytes in response to lipopolysaccharide and CD40 stimulation was equivalent in patients and controls. These results suggest that development of Th1 or Th2 memory cells in patients with XHIGM is unaffected by the absence of functional CD40 ligand. Rather, the susceptibility of these patients to intracellular pathogens, such as Pneumocystis carinii and Cryptosporidium parvum, is more likely to be due to an inability to activate the effector arm of the cellular immune response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10931152      PMCID: PMC1905692          DOI: 10.1046/j.1365-2249.2000.01307.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  40 in total

1.  Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors.

Authors:  H D Brightbill; D H Libraty; S R Krutzik; R B Yang; J T Belisle; J R Bleharski; M Maitland; M V Norgard; S E Plevy; S T Smale; P J Brennan; B R Bloom; P J Godowski; R L Modlin
Journal:  Science       Date:  1999-07-30       Impact factor: 47.728

2.  A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells.

Authors:  R J Noelle; M Roy; D M Shepherd; I Stamenkovic; J A Ledbetter; A Aruffo
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

Review 3.  Cytokine flow cytometry: understanding cytokine biology at the single-cell level.

Authors:  C Prussin
Journal:  J Clin Immunol       Date:  1997-05       Impact factor: 8.317

4.  The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells.

Authors:  M Roy; T Waldschmidt; A Aruffo; J A Ledbetter; R J Noelle
Journal:  J Immunol       Date:  1993-09-01       Impact factor: 5.422

5.  CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM.

Authors:  J P DiSanto; J Y Bonnefoy; J F Gauchat; A Fischer; G de Saint Basile
Journal:  Nature       Date:  1993-02-11       Impact factor: 49.962

Review 6.  CD40 ligand and its role in X-linked hyper-IgM syndrome.

Authors:  R E Callard; R J Armitage; W C Fanslow; M K Spriggs
Journal:  Immunol Today       Date:  1993-11

7.  Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA-1.

Authors:  L Tian; R J Noelle; D A Lawrence
Journal:  Eur J Immunol       Date:  1995-01       Impact factor: 5.532

Review 8.  CD40 ligand-CD40 interaction in Ig isotype switching in mature and immature human B cells.

Authors:  G Aversa; J Punnonen; J M Carballido; B G Cocks; J E de Vries
Journal:  Semin Immunol       Date:  1994-10       Impact factor: 11.130

9.  CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome.

Authors:  R C Allen; R J Armitage; M E Conley; H Rosenblatt; N A Jenkins; N G Copeland; M A Bedell; S Edelhoff; C M Disteche; D K Simoneaux
Journal:  Science       Date:  1993-02-12       Impact factor: 47.728

10.  The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome.

Authors:  A Aruffo; M Farrington; D Hollenbaugh; X Li; A Milatovich; S Nonoyama; J Bajorath; L S Grosmaire; R Stenkamp; M Neubauer
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

View more
  2 in total

1.  An imbalance of naive and memory/effector subsets and altered expression of CD38 on T lymphocytes in two girls with hyper-IgM syndrome.

Authors:  B T Costa-Carvalho; M A Viana; M K C Brunialti; E G Kallas; R Salomao
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

2.  Case Report: Hyper IgM Syndrome Identified by Whole Genome Sequencing in a Young Syrian Man Presenting With Atypical, Severe and Recurrent Mucosal Leishmaniasis.

Authors:  Camilla Heldbjerg Drabe; Rasmus L Marvig; Line Borgwardt; Jens D Lundgren; Hanne Vibeke Hansen Maquart; Terese Lea Katzenstein; Marie Helleberg
Journal:  Front Immunol       Date:  2020-09-11       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.